Rating Rationale
July 12, 2024 | Mumbai
Godrej Agrovet Limited
Rating reaffirmed at 'CRISIL A1+'; Rated amount enhanced for Commercial Paper
 
Rating Action
Rs.1200 Crore (Enhanced from Rs.1000 Crore) Commercial PaperCRISIL A1+ (Reaffirmed)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its 'CRISIL A1+' rating on the commercial paper programme of Godrej Agrovet Ltd (GAL).

 

The rating continues to factor in the diversified and healthy business risk profile of GAL which has presence in the animal feed, palm oil, crop protection, dairy, poultry and processed foods segments. The company is one of the leading players in the domestic organised animal feed industry and enjoys a substantial market share in the palm oil segment. The rating also factors in the company’s strong financial risk profile supported by healthy debt protection metrics, low gearing and healthy return indicators. The rating further factors in the financial flexibility enjoyed by GAL being part of the Godrej group.

 

These strengths are partially offset by susceptibility to volatility in raw material prices, intense competition in some of the business segments and vulnerability to weather conditions and government regulations. Nonetheless, the company's presence across diverse agriculture-related businesses mitigates these risks to some extent.

Analytical Approach

CRISIL Ratings has considered the consolidated business and financial risk profiles of GAL. This is because these entities, collectively referred to as Godrej Agrovet, have common promoters and are in similar lines of business.

 

Please refer Annexure - List of Entities Consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

  • Diversified business presence: The company’s focus on diversification into newer segments such as palm oil, crop protection, dairy and poultry over the past 7-8 fiscals in order to lower its concentration in the animal feed business (revenue contribution down to around 49.5% for the fiscal 2024 from 80% in fiscal 2012) supports its overall business risk profile and provides cushion against slowdown in any business segment.

 

In the fiscal 2024, overall revenue saw modest growth of 2% year-on-year, largely on account of healthy volume growth in most of the business segments, apart from the business under the subsidiary, Astec Lifesciences, which faced competitive pressures for its key enterprise products. The volume growth was offset by negative or modest expansion in realisations, especially in the palm oil, poultry and animal feed segments, leading to a muted revenue growth.

 

Operating margin, however, improved on a year-on-year basis, to 7.6% for the fiscal 2024, as against 5.7% for fiscal 2023, backed by lower input prices in dairy and poultry segments and higher operating levels in the animal feed and crop protection segments. The improvement in operating margin was the highest in crop protection segment, supported by strong volumes and realisations in the in-licensed product portfolio, apart from the dairy segment where operating margin improved substantially, on the back of lower milk procurement prices and operating efficiency, from operating losses seen last year. On the other hand, operating margin declined in the Astec Lifesciences segment, as it faced continued price erosion and subdued demand for its key enterprise product, despite robust performance by its contract manufacturing segment.

 

  • Dominant position in the domestic animal feed and palm oil segments: GAL enjoys a dominant position in the domestic organised animal feed industry with presence across various sub-categories such as cattle, broiler, layer, fish, shrimp and other feeds. The company's efforts are driven by research and development to achieve cost leadership and competitiveness, which have supported its volume growth. The segment continued to see traction across sub-segments, especially in cattle feed and aqua feed, during the fiscal 2024.

 

Being the second largest consumer of palm oil in the world, India’s demand for domestic palm oil is expected to remain robust. The segment registered compounded annual growth rate of 13% over the nine fiscals through 2024, with healthy operating margin of above 18% over the period. Strong volume growth expected over the medium term, along with the longer shelf-life volumes coming from company’s newly set up oil refinery, would help keep operating margins healthy.

 

  • Strong financial risk profile: Financial risk profile remains strong as reflected in gearing of 0.51 times as on March 31, 2024 and interest coverage of 7.27 times in the fiscal 2024, versus 0.55 times and 6.57 times, respectively, as on March 31, 2023. Debt levels declined slightly to Rs 1,309 crore as on March 31, 2024 from Rs 1,321 crore as on March 31, 2023. Debt levels are expected to remain range-bound over the medium term on the back of strong cash accruals from the business, despite the capital expenditure (capex) plan and working capital requirements, because of which the overall financial risk profile would remain comfortable.

 

  • Strong financial flexibility from being part of the Godrej group: GAL enjoys strong financial flexibility being part of the Godrej group and has the ability to raise debt at competitive rates and on short notice. It is able to directly derive implicit benefits being part of the Godrej group and without a formal arrangement of support with the parent, group companies or promoters.

 

Weaknesses:

  • Exposure to volatility in raw material and commodity prices and intense competition: Revenue and profitability remain susceptible to volatility in raw material and commodity prices in the animal feed, palm oil, dairy and poultry businesses. Given the intense competition in the animal feed business, the company's ability to pass on the increase in prices is with a lag or at times, limited. During the fiscal 2024, operating margin was impacted by high raw material cost in the animal feed segment. Also, revenue sharing with farmers in the palm oil business is formula driven and linked to international crude palm oil prices and hence revenue and operating margin remain susceptible to fluctuations in commodity prices.

 

  • Susceptibility to weather conditions and government regulations: Revenue and profitability are susceptible to weather conditions as well as government regulations. Nonetheless, the company's presence across diverse agriculture-related businesses mitigates these risks to some extent. In fiscal 2023, erratic monsoons in key states had impacted the application opportunities for agrochemicals in the crop protection segment. Also, the palm oil business has been impacted by extreme heat in the past, which resulted in lower oil extraction from fresh fruits, resulting in a decline in yield.

 

  • Working capital intensive operations in the crop protection business: Among the six business segments, the crop protection (including Astec) segment has large working capital requirement with receivables and inventory of 8-9 months and supported by creditors of 5-6 months. However, owing to minimal/negative working capital requirement in other key segments, the overall working capital cycle is relatively well managed.

Liquidity: Strong

Cash accrual (post-dividend) expected at Rs 400-600 crore each over fiscals 2025 to 2027 should comfortably cover annual debt servicing and majority of capex plans. Bank lines of about Rs 400 crore had minimal utilisation of 21% on average in the 12 months through December 2023. The working capital requirement is partially met through issuance of commercial paper worth around Rs 700 crore availed at attractive rates of 7.2% (as of April 2024). GAL enjoys strong financial flexibility being part of the Godrej group, which lends comfort to overall liquidity.

 

Environment, social and governance (ESG) profile

GAL’s ESG profile supports its healthy credit risk profile.

 

The animal feed and agrochemicals sectors have significant impact on the environment owing to higher emissions, waste generation and water consumption. The sector also has a significant social impact because of its large workforce across its own operations and value chain partners, and due to its nature of operations affecting local community and health hazards involved. GAL has been focusing on mitigating its environmental and social risks.

 

Key ESG highlights:

  • As part of the vision, the company aspires to develop products which consume fewer resources (energy, water), emit fewer greenhouse gases and include recyclable, renewable or natural materials to the maximum possible extent, through extensive research.
  • 77% of GAL’s energy consumption during the fiscal 2024 was from clean, renewable sources, as against a target of 90% by 2026. Its oil palm facilities use of waste of fruit bunches as renewable boiler fuel, which has led to around 99.8% energy being generated through renewable energy sources.
  • GAL is a 20 times water positive company, having sequestered around 37 million cubic metres of water during fiscal 2024.
  • Company became one of the first agri companies in India to commit to reduction in Scope 1 & Scope 2 GHG emissions by 37.5% and Scope 3 emissions by 16.0% by 2035.
  • The governance structure is characterised by 50% of the board members being independent directors, dedicated investor grievance redressal system and extensive disclosures. The company’s chairman and executive positions are also split.

 

There is growing importance of ESG among investors and lenders. GAL’s commitment to ESG will play a key role in enhancing stakeholder confidence, given access to domestic capital markets.

Rating Sensitivity factors

Downward factors:

  • Significant decline in revenue and profitability impacting accrual and return indicators
  • Large debt-funded acquisition or capex impacting the financial risk profile with gearing of more than 1 time on a sustained basis

About the Company

GAL, part of the Godrej group, has presence across the animal feed, palm oil, crop protection, dairy, poultry and processed foods segments with 50+ facilities and a wide distribution network across the country. The company is one of the largest organised animal feed manufacturers in India offering cattle, layer, broiler, shrimp, fish and other feeds. In addition, GAL has interests in animal feed through its joint venture, ACI Godrej Agrovet Pvt Ltd in Bangladesh.

 

In the crop protection business, the company has products across the insecticides, fungicides and plant growth regulator segments with a pan-India network of ~6,600 distributors. Through its subsidiary Astec, GAL is involved in the manufacturing and sale of intermediates, active ingredients and formulations.

 

In the palm oil segment, GAL has palm tree plantations across nine states for producing crude palm oil and palm kernel.

 

The company has presence in the dairy segment through its subsidiary Creamline Dairy Products Ltd ('CRISIL AA-/Stable/CRISIL A1+') and in the processed poultry and vegetarian food products segment through Godrej Tyson Foods Ltd.

Key Financial Indicators

As on/for the period ended March 31

Unit

2024

2023

Revenue

Rs crore

9577

9385

Profit after tax (PAT)

Rs crore

358

294

PAT margin

%

3.7

3.1

Adjusted debt/Adjusted networth

Times

0.51

0.6

Interest coverage

Times

7.27

6.6

Any other information: Not Applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN Name of the
instrument
Date of
Allotment
Coupon
Rate (%)
Maturity
Date
Issue size
(Rs. Crore)
Complexity
Level
Rating assigned
with outlook
NA Commercial paper NA NA 7 to 365 Days 1200 Simple CRISIL A1+

Annexure – List of entities consolidated

Name of entity Extent of consolidation Rationale for consolidation
Godvet Agrochem Ltd Full Subsidiary
Astec LifeSciences Ltd Full Subsidiary
Behram Chemicals Pvt Ltd Full Subsidiary
Comercializadora Agricola Agroastrachem Cia Ltda Full Subsidiary
Creamline Dairy Products Ltd Full Subsidiary
Godrej Tyson Foods Ltd Full Subsidiary
Godrej Cattle Genetics Pvt Ltd (earlier known as Godrej Maxximilk Pvt Ltd) Full Subsidiary
ACI Godrej Agrovet Pvt Ltd Equity JV
Omnivore India Capital Trust Equity JV
Al Rahba International Trading Limited Liability Equity Associate (upto April 18, 2023)
Company, United Arab Emirates
Annexure - Rating History for last 3 Years
  Current 2024 (History) 2023  2022  2021  Start of 2021
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Commercial Paper ST 1200.0 CRISIL A1+ 10-05-24 CRISIL A1+ 28-04-23 CRISIL A1+ 25-05-22 CRISIL A1+ 26-05-21 CRISIL A1+ CRISIL A1+
      -- 25-04-24 CRISIL A1+   --   --   -- --
All amounts are in Rs.Cr.
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Manish Kumar Gupta
Senior Director
CRISIL Ratings Limited
B:+91 124 672 2000
manish.gupta@crisil.com


Anand Kulkarni
Director
CRISIL Ratings Limited
B:+91 22 3342 3000
anand.kulkarni@crisil.com


Vishisht Lalwani
Rating Analyst
CRISIL Ratings Limited
B:+91 22 3342 3000
Vishisht.Lalwani1@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') provided by CRISIL Ratings Limited ('CRISIL Ratings'). For the avoidance of doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for use only within the jurisdiction of India. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings provision or intention to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

The report is a statement of opinion as on the date it is expressed, and it is not intended to and does not constitute investment advice within meaning of any laws or regulations (including US laws and regulations). The report is not an offer to sell or an offer to purchase or subscribe to any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way.

CRISIL Ratings and its associates do not act as a fiduciary. The report is based on the information believed to be reliable as of the date it is published, CRISIL Ratings does not perform an audit or undertake due diligence or independent verification of any information it receives and/or relies on for preparation of the report. THE REPORT IS PROVIDED ON “AS IS” BASIS. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAWS, CRISIL RATINGS DISCLAIMS WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR OTHER WARRANTIES OR CONDITIONS, INCLUDING WARRANTIES OF MERCHANTABILITY, ACCURACY, COMPLETENESS, ERROR-FREE, NON-INFRINGEMENT, NON-INTERRUPTION, SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE OR INTENDED USAGE. In no event shall CRISIL Ratings, its associates, third-party providers, as well as their directors, officers, shareholders, employees or agents be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

The report is confidential information of CRISIL Ratings and CRISIL Ratings reserves all rights, titles and interest in the rating report. The report shall not be altered, disseminated, distributed, redistributed, licensed, sub-licensed, sold, assigned or published any content thereof or offer access to any third party without prior written consent of CRISIL Ratings.

CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains or its associates. Ratings are subject to revision or withdrawal at any time by CRISIL Ratings. CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.

CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For more detail, please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.  Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the Securities and Exchange Board of India regulations (and other applicable regulations, if any), are made available on its websites, www.crisilratings.com and https://www.ratingsanalytica.com (free of charge). CRISIL Ratings shall not have the obligation to update the information in the CRISIL Ratings report following its publication although CRISIL Ratings may disseminate its opinion and/or analysis. Reports with more detail and additional information may be available for subscription at a fee.  Rating criteria by CRISIL Ratings are available on the CRISIL Ratings website, www.crisilratings.com. For the latest rating information on any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301. 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisilratings.com/en/home/our-business/ratings/credit-ratings-scale.html